Ethris Competitors and Similar CompaniesClear all

Ethris's competitors and similar companies include Ambrx and Ocugen.

	Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.	Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.	Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases
Founding Date	Founding Date 2009	Founding Date 2003	Founding Date 2013
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations Planegg, DE HQ	Locations San Diego, US HQ	Locations Malvern, US HQ
Employees	Employees 504% decrease	Employees 70	Employees 84425% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.8 b	Valuation ($) 292.1 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $7.4m (FY, 2022)	Revenue (est.) $4.4m (FY, 2025)
Net income	Net income N/A	Net income ($78m) (FY, 2022)	Net income ($67.8m) (FY, 2025)

For sources of this data, please see the company profile

San Diego, US

Employees

Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.

Malvern, US

Employees

Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases

Financial